Adocia Operating Margin from 2010 to 2026
| ADOC Stock | EUR 6.97 0.36 5.45% |
Check Adocia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adocia's main balance sheet or income statement drivers, such as Interest Expense of 657.6 K, Total Revenue of 10.7 M or Research Development of 19.3 M, as well as many indicators such as Price To Sales Ratio of 10.9, Dividend Yield of 0.0 or Days Sales Outstanding of 712. Adocia financial statements analysis is a perfect complement when working with Adocia Valuation or Volatility modules.
Adocia | Operating Margin |
Analyzing Adocia's Operating Margin over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Margin has evolved provides context for assessing Adocia's current valuation and future prospects.
Latest Adocia's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Adocia over the last few years. It is Adocia's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adocia's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (4.06) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Adocia Operating Margin Regression Statistics
| Arithmetic Mean | (7.78) | |
| Coefficient Of Variation | (153.98) | |
| Mean Deviation | 8.95 | |
| Median | (1.52) | |
| Standard Deviation | 11.98 | |
| Sample Variance | 143.54 | |
| Range | 42.0483 | |
| R-Value | 0.33 | |
| Mean Square Error | 135.97 | |
| R-Squared | 0.11 | |
| Significance | 0.19 | |
| Slope | 0.79 | |
| Total Sum of Squares | 2,297 |
Adocia Operating Margin History
About Adocia Financial Statements
Adocia stakeholders use historical fundamental indicators, such as Adocia's Operating Margin, to determine how well the company is positioned to perform in the future. Although Adocia investors may analyze each financial statement separately, they are all interrelated. For example, changes in Adocia's assets and liabilities are reflected in the revenues and expenses on Adocia's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Adocia. Please read more on our technical analysis and fundamental analysis pages.
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Adocia SA was founded in 2005 and is headquartered in Lyon, France. ADOCIA operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 116 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Adocia Stock
Adocia financial ratios help investors to determine whether Adocia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Adocia with respect to the benefits of owning Adocia security.